Contact UsSiteMap
Home Entertainment community Fashion Positive energy More

Kids

The International Innovation Awards 2024 Honors Dhanarak Asset Development Co., Ltd.'s GovComplex Application

KUALA LUMPUR,Malaysia,Dec. 10,2024-- TheGovComplex Application,developed by Dhanarak Asset Development (DAD),has been recognized under the Service and Solution category at the International Innovation

12-11

JULO Becomes First Fintech in Indonesia to Guarantee Instant 10-Minutes Disbursement

JAKARTA,Indonesia,Dec. 10,2024-- JULO,Indonesia\'s leading fintech offering Virtual Credit Card features,has just raised the bar in digital financial services by launching a first-of-its-kind guarante

12-11

Stellantis and CATL to Invest Up to €4.1 Billion in Joint Venture for Large-Scale LFP Battery Plant in Spain

Joint venture to build an all-new lithium iron phosphate (LFP) battery plant at Stellantis\' Zaragoza,Spain site

12-11

From Swipes to Connections: Cake Meet Simplifies Professional Networking

HO CHI MINH CITY,Vietnam,Dec. 10,2024-- Cake Meet,developed by Cake,a Taiwan-originated Global Talent Platform with over 7M users,is revolutionizing professional networking across Asia.

12-11

Arcfra Partner Day 2024 Successfully Held in Seoul

SEOUL,South Korea,Dec. 10,2024-- Arcfra Pte. Ltd. (hereinafter referred to as "Arcfra," arcfra.com),a leading innovator in cloud infrastructure and full-stack solutions,hosted its first even

12-11

Clarifai and Getty Images Announce Strategic Engagement to Make AI-Generated Images Available to Clarifai Customers

Agreement Ensures AI-Generated Images Are Responsibly Sourced,Legally Protected,and Safe for Commercial Use

12-11

Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib

ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med

12-11

Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report

ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024--Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet medi

12-11

【2024 ASH】TransThera Announces the Phase I Study Results of TT-01488, a Novel Non-Covalent BTK Inhibitor, in Patients with Relapsed or Refractory B-cell Malignancies

NANJING,China and GAITHERSBURG,Md.,Dec. 10,2024--TransThera Sciences (Nanjing),Inc. (the "TransThera"),a clinical demand-oriented,registrational clinical stage biopharmaceutical company focu

12-11

Xinhua Silk Road: Climate investment and financing under spotlight at key conference held in S. China's Guangzhou Nansha

BEIJING,Dec. 11,2024-- Guests from home and abroad shared experiences in climate investment and financing as well as reached consensus on addressing climate change on December 8 as they gathered in Na

12-11

Home Previous 6 7 8 9 10 11 12 Next Tail

10 Items Per Page (Page 9 / 41) Total 405 Items

Disclaimer

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.
©copyright2009-2020Life Management Weekly    Contact Us SiteMap